An Open Label Study of Solifenacin Succinate (VESIcare®) for the Treatment of Overactive Bladder in Parkinson’s Disease
Kelly L. Sullivan
Part of the Epidemiology Commons
Works by Raul Ordorica in Epidemiology
2018
URGE-PD: A Multi-Site, Double-Blind, Randomized, Placebo-Controlled Trial of Solifenacin succinate (VESIcare®) for the Treatment of Overactive Bladder in Parkinson’s Disease
Kelly L. Sullivan
2015
Randomized, Controlled Pilot Trial of Solifenacin Succinate for Overactive Bladder in Parkinson's Disease
Kelly L. Sullivan